CGP 57380,
CGP-57380,
CGP57380,
CGP 57380,
522629-08-9,
CGP-57380,
MNK1 Inhibitor,
CGP57380,
N3-(4-fluorophenyl)-1h-pyrazolo[3,4-d]pyrimidine-3,4-diamine,
CHEMBL1240885,
C11H9FN6,
4-Amino-5-(4-fluoroanilino)-pyrazolo[3,4-d]pyrimidine,
SCHEMBL987991,
CHEMBL576817,
GTPL6010,
SCHEMBL16714452,
CHEBI:92749,
DTXSID50469941,
HMS3229K20,
HMS3263L14,
HMS3269P13,
HMS3648M14,
HMS3653G22,
HMS3677D16,
Tox21_501256,
2314AH,
BDBM50130693,
BDBM50298223,
IN1236,
MFCD03861062,
NSC741567,
s7421,
ZINC13816313,
AKOS024457265,
CCG-206868,
LP01256,
NSC-741567,
NCGC00162380-01,
NCGC00162380-02,
NCGC00162380-03,
NCGC00162380-06,
NCGC00261941-01,
AK298902,
EN002593,
QC-10494,
AB0098119,
B3570,
SW219758-1,
CGP 57380, >=98% (HPLC),
SR-02000000869,
SR-02000000869-2,
BRD-K42500029-001-01-9,
N-(4-fluorophenyl)-3H-pyrazolo[3,4-d]pyrimidine-3,4-diamine,
3-N-(4-Fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidine-3,4-diamine,
3-N-(4-fluorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-3,4-diamine,
N3-(4-Fluorophenyl)-1H-pyrazolo-[3,4-d]pyrimidine-3,4-diamine,
D0A7FQ,
CID11644425,
A13883,
C466997,